HHTM

AURORA, ILLINOIS – Sonova USA Inc. today announced a leadership transition within its Hearing Instruments (HI) business. Jimena Garcia, formerly Vice President of Marketing Wholesale for U.S. Hearing Instruments, has been appointed Vice President of Commercial Sales. In her new role, Garcia will lead commercial operations for both the Phonak and Unitron brands. The appointment reflects Sonova USA’s ongoing efforts

Phonak has introduced the Virto R Infinio, its first fully rechargeable custom in-the-ear hearing aid. Built on the Infinio platform, Virto R offers a deeply recessed, discreet fit while delivering the same advanced performance as Phonak’s behind-the-ear models. Key features include RightFit technology for personalized acoustics, biometric calibration for optimized directionality, and AutoSense OS 7 trained on 18x more real-life

For the first time, optical coherence tomography (OCT) is being used to study the human inner ear directly in patients. In this follow-up conversation, Dr. John Oghalai, Professor and Chair of the Caruso Department of Otolaryngology at USC, shares the latest advances in this groundbreaking research. Dr. Oghalai describes how his team has transitioned from animal studies to human imaging,

CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic (“off the shelf”) cell therapies for neurological and ophthalmic conditions, announced it has entered into a research collaboration with William Demant Invest A/S (WDI). WDI is the holding company for William Demant Foundation’s investment activities and the majority shareholder of Demant A/S,

LYNGE, DENMARK – August 25, 2025 – Signia has announced the launch of the Insio Charge&Go CIC IX, described as the first rechargeable, custom completely-in-canal (CIC) hearing aid with directional microphone technology. The device provides up to 35 hours of battery life and has been shown to deliver five times greater speech enhancement in noise compared to single-microphone CIC hearing

What if a cochlear implant could adapt and improve throughout a patient’s lifetime? Hearing health advocate and author Gael Hannan sits down with Brendan Murray, Vice President of CI Product Portfolio at Cochlear, to discuss the launch of the Cochlear™ Nucleus® Nexa™ System. The Nexa is the first cochlear implant platform with upgradeable firmware, allowing recipients to benefit from future

ISELIN, NEW JERSEY – Signia, part of WSA, announced the addition of three new hearing aid form factors to its Integrated Xperience (IX) platform: the Insio IX ITC/ITE (In-the-Canal/In-the-Ear) custom-fit hearing aids and the Motion Charge&Go IX family of rechargeable behind-the-ear (BTE) hearing aids. The Motion Charge&Go SP IX model offers up to 65 hours of battery life, the longest

Addressing hearing loss earlier in life could help protect brain health decades later. A new study published in JAMA Neurology reports that people with hearing loss who begin using hearing aids in their 60s may significantly lower their risk of developing dementia. The findings suggest that the timing of intervention matters: while hearing aids reduced dementia risk in participants under

IRVINE, CALIFORNIA – InnoCaption, an FCC-certified provider of real-time captioning of phone calls for the deaf and hard-of-hearing community, announced that it has ranked No. 2,474 on the 2025 Inc. 5000 list of America’s fastest-growing private companies. The Inc. 5000 is widely recognized as a benchmark for entrepreneurial success, highlighting innovative businesses driving growth across the U.S. economy. “InnoCaption has

VANCOUVER, CANADA – August 21, 2025 – NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics, announced new preclinical results from two Department of Defense-sponsored studies. The studies investigated NVG-291-R, the rodent variant of the company’s lead candidate NVG-291, in models of blast-induced sensorineural hearing loss and peripheral nerve injury. Findings presented at the